![\"\"](\"https:\/\/static.euronews.com\/website\/images\/logos\/logo-euronews-stacked-outlined-72x72-grey-9.svg\"){kind=logo}
\n ADVERTISEMENT<\/p>\n
\n ADVERTISEMENT<\/p>\n
On Monday, the White House stated that it had identified a connection between the use of paracetamol in pregnancy \u2013 marketed in the US as Tylenol \u2013 and autism in children.\u00a0<\/p>\n
US President Donald Trump went further, claiming that Tylenol “is no good” and that pregnant women should “fight like hell” to avoid taking it. He had teed up the news over the weekend, saying \u201cI think we found an answer to autism\u201d.<\/p>\n
The EMA stated that there is no evidence to support these claims. \u201cThere is no new evidence that would require changes to the current EU recommendations for use,\u201d an agency spokesperson told Euronews.<\/p>\n
In 2019, the Agency reviewed studies<\/a> on the neurodevelopment of children exposed to paracetamol during pregnancy and concluded that the findings were inconclusive, with no evidence of a link to neurodevelopmental disorders.\u00a0<\/p>\n The EMA now states that extensive data from pregnant women who used paracetamol during pregnancy shows no increased risk of malformations in the developing foetus or in newborns \u2013 information already included in product labelling in the EU.\u00a0<\/p>\n \u201cWhen needed, paracetamol can be used during pregnancy. However, the advice is to use it at the lowest effective dose, for the shortest possible time and as infrequently as possible,\u201d the spokesperson added. \u00a0<\/p>\n As with all medicines, the EMA and national competent authorities in the EU carry out continuous safety monitoring of products containing paracetamol.\u00a0<\/p>\n The announcement from the Trump administration followed a pledge<\/a> by US health secretary Robert F. Kennedy Jr in April to identify the cause of autism by September.\u00a0<\/p>\n